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Priapism is a prolonged penile erection that is unrelated to sexual stimulation. Low-flow
priapism has been associated with sickle cell disease and other hemoglobinopathies,
neoplastic syndrome, anticoagulant therapy, psychotropic medication, and idiopathic causes.
We report the successful treatment of idiopathic low-flow priapism using the Winter
procedure. Initial treatment consisted of aspiration and intracavernous irrigation with iced
saline and a vasoconstrictive agent, but in vain. We then performed the Winter procedure,
in which fistulas between the corpora cavernosa and the glans penis were created. This
resulted in the simultaneous detumescence of the penis, without complication. The erectile
function of the penis was normal 1 year after the procedure. This case shows that idiopathic
low-flow priapism can be successfully treated using the Winter procedure when conservative
treatment fails.
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Priapism is the persistence of an erection that does not
result from sexual desire and fails to subside despite
orgasm. Recent advances in the understanding of
erectile physiology have improved the prompt
diagnosis and treatment of priapism [1, 2]. Normally,
low-flow priapism is effectively treated with
intracavernous vasoconstrictive agents or surgical
shunting [3–13]. We report the successful treatment of
low-flow priapism using the Winter procedure
(creating fistulas between the corpora cavernosa and
the glans penis) [7].
CASE PRESENTATION
This 60-year-old man presented with a penile erection
of 5 days’ duration. Initially, he sought the help of a
local medical doctor, and intracavernous irrigation
was done, but in vain. He was then transferred to our
urologic outpatient department and intracavernous
irrigation with vasoconstrictive epinephrine was
performed. Priapism recurred 1 hour later.
The patient reported no history of pelvic trauma or
medication use. He also denied that he had previously
received intracavernous injections for erectile
dysfunction. Physical examination revealed a rigid
penis and flaccid glans associated with pain. Blood gas
analysis of aspirated intracorporeal blood showed a
pH of 6.906, pO2 of 17 mmHg, and pCO2 of 62.4 mmHg.
Laboratory data demonstrated a white count of
21,580/μL normal peripheral blood differential cell
count, no evidence of hemolysis or immature cells on
the blood smear, and a negative urinalysis. Thus, idi-
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opathic low-flow priapism was suspected.
During the period of admission, intracavernous
irrigation with vasoconstrictive epinephrine and ice-
water enema were performed, but to no effect. Thus,
we decided to perform the Winter procedure for
priapism. With the patient under epidural anesthesia,
two 16-gauge needles were inserted into the dorsal
glans, through which the corpora cavernosa were as-
pirated and irrigated free of stagnant blood (Figure 1).
Both needles were removed 30 minutes after dilata-
tion from the fistulas between the glans and the
cavernosa. Milking of the glans assured patency of the
fistulas after needle removal. Old blood oozed from
the wounds of the glans during milking, and penis
detumescence progressed (Figure 2). The patient was
instructed to milk the glans repeatedly and frequently
during the next 48 hours to keep the fistulas between
the glans and the cavernosa open to ensure good
venous flow and detumescence. The glans penis was
not sutured. Penile detumescence was noted 2 days
later, without further complication.
During follow-up of more than 1 year, the patient
reported that sexual arousal remained normal and
erectile function was satisfactory.
DISCUSSION
Priapism is a prolonged pathologic erection unrelated
to sexual stimulation, which arises from an abnormal
imbalance between the arterial blood supply to the
penis and the venous return. Two forms of priapism
are recognized: veno-occlusive or low-flow priapism
and arterial or high-flow priapism [1, 2].
High-flow (arterial) priapism is usually the result
of straddle injury and is characterized by a painless,
persistent semi-rigid erection. Because no ischemia
results, treatment of this type of priapism may be
elective [14]. However, low-flow priapism is a urologic
emergency. The long-term sequelae of this more pain-
ful condition include erectile dysfunction or repeated
episodes of prolonged priapism [15].
Commonly described etiologies of low-flow
priapism include sickle cell disease and other
hemoglobinopathies, malignancy, medication, and
idiopathic causes [14, 16–18]. Common medications
reported to cause priapism include phenothiazines,
antihypertensive agents, and anticoagulants [19].
There are two peaks in the age distribution of
patients with priapism [18]. The first peak occurs in
children between the age of 5 and 10 years and the
second peak occurs in men between the age of 20 and
50 years.
Assessment of the patient with priapism should
include searching for one or more of the common risk
factors. A detailed history should include assessment
of pain, history of systemic symptoms consistent with
a malignancy or hemoglobinopathy, recent history of
trauma or medication use, and complete medical and
family histories of genitourinary problems [20].
Physical examination of the patient should include a
careful assessment of the glans, corpora spongiosum,
and corpora cavernosa of the penis. Examination of
patients with priapism often reveals a flaccid corpora
spongiosum and glans, but bilaterally erect corpora
cavernosa [19].
Figure 2. Postoperative penile detumescent state, without sutures
in the glans penis.
Figure 1. Erect penis showing placement of the two 16-gauge
needles (arrow) used for the Winter procedure.
Kaohsiung J Med Sci February 2003 • Vol 19 • No 2
C.C. Chen, C.J. Wang, C.W. Chen, et al
90
Blood gas analysis of aspirated intracorporeal blood
can help differentiate between high-flow and low-
flow priapism [21]. Low-flow priapism is suggested
by pH of less than 7.25, pO2 less than 30 mmHg, and
pCO2 greater than 60 mmHg [22]. Doppler ultrasound
also helps differentiate between priapism character-
ized by low flow or high flow [14].
Treatment of priapism should be based on the
underlying cause. A wide variety of treatment options
have been proposed for patients with idiopathic
priapism, including the use of ice packs, pressure
dressings, ice-water enemas, hot-water enemas,
prostatic massage, sedatives, analgesics, estrogens,
amyl nitrate, systemic anticoagulation, vasodilators,
and general anesthesia [18, 23–25].
In addition, simple intracorporeal aspiration will
a c c o m p l i s h  p e r m a n e n t  d e t u m e s c e n c e  i n
approximately half of the patients. This may be
accompanied by injection of pharmaceutical agents to
counteract α-blockade if drugs were used initially to
create the erection [3–6].
When detumescence is not achieved, a Tru-Cut
(Travenol Laboratories Inc, Deerfield, IL, USA) bi-
opsy needle can be used to create fistulas or windows
(Winter procedure) in the fibrous albuginea between
the glans and corpora cavernosa [7]. Various modifi-
cations to the Winter procedure have been described
using an angiocatheter with side holes [8], a modified
trocar with side holes [9], or a Kerrison rongeur for
creating a glandular-corporal shunt. If the percutane-
ous shunt fails, an open glandular-cavernosal shunt is
recommended. The Al-Ghorab operation, which em-
ploys a subcoronal incision with removal of the distal
tunica albuginea of the corpora cavernosa, is suggested.
The subsequent glandular-cavernosal shunt results in
detumescence in most cases, with a theoretical de-
crease in complications due to direct visualization of
the corpora [10].
In the rare case of shunt failure, a more proximal
approach to shunt placement can be performed. Shunts
between the corpora cavernosa and spongiosum [11],
dorsal vein [12], and saphenous vein [13] have been
described.
One of the most important features of postoperative
priapism management is to have the patient, hospital
personnel or family members intermittently squeeze
the penis every few minutes during the first few hours
and frequently during the first 24 hours to keep the
penis detumescent [18].
Priapism-induced corporal fibrosis with resultant
erectile dysfunction is almost universal in untreated
for 24 hours, low-flow priapism. Nonetheless, even
with optimal treatment, patients may still develop
erectile dysfunction [26]. In a large Finnish series of
124 cases, Kulmala and co-workers [27] reported that
erectile dysfunction was found in 69% of men treated
conservatively versus 31% of those treated surgically
with a glandular-cavernosal shunt.
We report a rare case of idiopathic low-flow pria-
pism in Taiwan that was successfully treated using the
Winter procedure [28]. The Winter procedure pro-
vides an alternative treatment for patients with idi-
opathic low-flow priapism who do not respond to
conservative management. This simple procedure
usually resolves the priapism and facilitates the return
of normal erectile function.
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